The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDillistone Regulatory News (DSG)

Share Price Information for Dillistone (DSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.50
Bid: 10.50
Ask: 12.50
Change: 2.00 (21.05%)
Spread: 2.00 (19.048%)
Open: 10.00
High: 11.50
Low: 10.00
Prev. Close: 9.50
DSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results & Investor Presentation

26 Apr 2022 07:00

RNS Number : 2752J
Dillistone Group PLC
26 April 2022
 

 

Dillistone Group Plc("Dillistone", the "Company" or the "Group")Final Results

& Investor Presentation

 

Dillistone Group Plc ("Dillistone", the "Company" or the "Group"), the AIM quoted supplier of software for the international recruitment industry, is pleased to announce its audited final results for the 12 months ended 31 December 2021.

 

Highlights:

 

· Performance ahead of expectations

o Revenue £5.6m (2020: £6.3m)

o Incoming orders up 18% in 2021 compared to 2020

o EBITDA1 £1.0m (2020: £1.2m)

o Group returns to breakeven for the year (2020: £0.7m loss)

o Net debt £1.0m (2020: £0.9m)

o Cash at year end was £0.8m (2020: £1.3m)

 

· Recurring revenues2 represent 89% (2020: 91%) of Group revenue

· Secured largest new Group client since the restructuring of the business in January 2020

· Continued product development expenditure supporting strong start to 2022

· Talentis showing strong momentum going into 2022

 

Definitions:

1. Amounts based on segment EBITDA figures - see note 5

2. The component elements of recurring revenue are detailed in note 5.

 

Commenting on the results and prospects, Giles Fearnley, Non-Executive Chairman, said:

 

"In my interim statement I highlighted that in our business, where a large part of our revenue is contracted annually in advance, the impact of Covid would be felt throughout the remainder of 2021. This proved to be the case as recurring revenue decreased by 13% to £5.0m (89% of Group revenue (2020: 91%)) however we saw an uplift in orders in Q4 to pre-pandemic levels.

 

"The current year has begun well following on from the strong finish to 2021. Growth in new business sales is helping us recover recurring revenue lost during the pandemic and, while we are conscious of the potential impact of ongoing economic turbulence, we are confident that the Group is well on the way to recovery, with positive signs across our entire product range and an exciting opportunity opening up with our new Talentis product."

Investor Presentation - 1pm on Thursday 28 April 2022

Jason Starr, Chief Executive, and Joanne Curd, Chief Financial Officer, will hold a remote presentation at 1pm on Thursday 28 April 2022 to review the results and introduce the Talentis executive search platform, Dillistone's latest software release. Those interested in attending should register at https://register.gotowebinar.com/register/9054920680771381264 or enquire at Dillistone@walbrookpr.com, or 0797 122 1972.

Annual Report and Accounts - The final results announcement can be downloaded from the Company's website (www.dillistonegroup.com). Copies of the Annual Report and Accounts (in addition to the notice of the Annual General Meeting) will be sent to shareholders by 20 May 2022 for approval at the Annual General Meeting to be held on 15 June 2022.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Enquiries:

Dillistone Group Plc

 

 

 

Giles Fearnley

Chairman

Via Walbrook PR

 

Jason Starr

Chief Executive Officer

 

 

Joanne Curd

Chief Financial Officer

 

 

 

 

 

 

WH Ireland Limited (Nominated adviser)

 

 

Chris Fielding

Managing Director, Corporate Finance

020 7220 1650

 

 

 

 

 

Walbrook PR

 

 

 

Tom Cooper / Paul Vann

 

tom.cooper@walbrookpr.com

 

 

 

020 7933 8780

 

 

 

0797 122 1972

 

 

 

 

 

            

Notes to Editors:

Dillistone Group Plc is a leader in the supply and support of software and services to the recruitment industry. Dillistone operates through the Ikiru People (www.IkiruPeople.com) brand.

 

The Group develops, markets and supports the Talentis, FileFinder, Infinity, Mid-Office, ISV and GatedTalent products.

 

Dillistone was admitted to AIM, a market operated by the London Stock Exchange plc, in June 2006.

 

Learn about our products:

Talentis Software: https://www.talentis.global/recruitment-software/

Voyager Software: https://www.voyagersoftware.com

GatedTalent Services: https://www.talentis.global/optimization-services/

 

 

 

CHAIRMAN'S STATEMENT

 

After a challenging few years for the business, I am pleased to report a year of progress and improvement, along with a sense that the business is in a position to progress further in 2022.

 

In my interim statement I highlighted that in our business, where a large part of our revenue is contracted annually in advance, the impact of Covid would be felt throughout the remainder of 2021. This proved to be the case, however we saw an uplift in orders in Q4 2021 to pre-pandemic levels.

 

Total revenue for the year was down 12% to £5.599m, with recurring revenue falling 13% to £5.009m. There was an adjusted operating loss in 2021 of £0.140m (2020: loss £0.166m) before acquisition related and other costs. Administration costs reduced by 14% excluding acquisition related items and other costs, depreciation and amortisation. The operating loss, including reorganisation and acquisition related items, was £0.199m (2020: loss £0.821m).

 

We maintained our investment in product development at £0.987m (2020: £0.969m) which we view as key to the future growth of the Group. January 2021 saw the launch of Talentis (https://www.talentis.global/recruitment-software/insights/). After a slow start, Talentis is now growing rapidly and the Group is excited by the opportunity that it presents.

 

In June 2021 we made the final payment of the 2 year bank loan that was secured in June 2019 and the following month we commenced monthly payments on the Government CBIL loan that we secured in June 2020 and which had a 12 month grace period for capital repayments.

 

Dividends

The Group is not recommending a final dividend in respect of the year to 31 December 2021 (2020: nil).

Staff

I and the Board would like to pay tribute to our employees across the Group, acknowledging their commitment and contribution in facing the challenges of the last 12 months. They have risen to these challenges and continued to deliver for our clients.

 

Corporate governance

It is the Board's duty to ensure that the Group is managed for the long-term benefit of all stakeholders.

During the year in review, we welcomed Steve Hammond to the Group Board in January 2021 and Joanne Curd in October. Steve joined as the Chief Engineering Officer for the Group with responsibility for the development of all group products. Joanne became our Chief Financial Officer replacing Julie Pomeroy who moved to a Non-executive Director role for 12 months, enabling us to continue to benefit from her expertise. I would also like to thank Alex James who stepped down from the Board in September having contributed extensively to the business over very many years.

Details of our governance processes and my role as Chairman of the Board are included in the corporate governance section that follows the Strategic Report.

Outlook

The current year has begun well following on from the strong finish to 2021.

 

Compared to the same period to 31 March in 2021, Q1 2022 incoming orders are up by 41%, with all products performing broadly in line with, or better than management expectations.

 

Our contingency recruiting products have enjoyed a strong start, driven by increasingly strong performance by our Infinity product, which is proving to be especially successful in the UK temporary recruitment sector.

 

In late 2021, we announced our largest new contract win since the Group's restructuring, and we are pleased to announce that this implementation of Infinity is now live and performing well.

 

Our executive search products, Talentis, FileFinder and GatedTalent, have also enjoyed a strong start to the year. Talentis was launched in early 2021 and, after a slow start, started to grow rapidly in the final weeks of 2021. While recurring revenue reflects the slow start, we are pleased to report that recurring revenue associated with the product is currently doubling every three months, and is comfortably on track to maintain this into Q2 2022. Driven by Talentis sales, March 2022 was, in terms of the number of new executive search firm contract wins, the Group's best ever month, beating the previous best of March 2010. While the majority of clients are small, the Group expects this to change over time. While growing rapidly, annualised recurring Talentis revenue is currently in mid five figures.

 

The Group continues to operate with a much lower cost base and as revenues recover, the improved operational leverage, following the efficiencies realised, will be reflected in overall performance. The Group is trading in line with market expectations, holding £0.764m in cash as at 31 December 2021 and does not expect to raise additional funds.

 

Taking the above into account, the Board is optimistic for the future and will issue a further update at the time of the AGM.

 

Giles Fearnley

Non-Executive Chairman

 

 

 

CEO's Review

Dillistone Group Plc is a global leader in the supply of solutions and services to the recruitment sector worldwide, in both contingency recruitment and executive search.

Contingency Recruitment Sector:

In the contingency recruitment sector, our products are primarily, but not exclusively, used by UK recruitment agencies. Our products serving this sector are:

 

· ISV.Online is an online skills testing product used by both recruitment agencies and corporate recruiters and has a strong international footprint. It allows recruiters and HR professionals to test individuals using our extensive portfolio of existing tests or to create their own unique tests to meet their requirements.

· MidOffice is a comprehensive pay & bill solution that allows recruitment businesses and back office service providers to process timesheets and bridges the gap between paying workers and invoicing clients. It can be used standalone or integrated to other recruitment systems including our Infinity product.

· Infinity is an established recruitment CRM used primarily by agencies in the UK, but also with users in Asia and Australia. It enables recruitment businesses to manage prospects, clients, candidates and jobs in one place and offers deep integration to Office365 and other recruitment industry complementary solutions. It is one of the few solutions in the UK market with extensive functionality for permanent, contract and temporary jobs all in one system.

 

During 2021

 

· We continued our ongoing investment in Infinity to give users in all recruiting sectors additional benefits including: more comprehensive application programming interfaces (APIs), more features to support remote recruitment, improved security and further efficiencies in the temporary recruitment workflows.

· December 2021 saw us win our largest new Infinity client since the restructuring of the business in January 2020. The implementation has been delivered successfully in 2022.

· Mid-Office is also furthering the temporary recruitment efficiencies we've added to Infinity by taking these all the way through to the pay and bill system and into the back office.

· ISV remains in its strong market position and is used by over half of the UK's top 10 recruitment agencies. There is strong retention among key accounts with significant multiple year renewals and an increased number of new client wins.

 

Executive Search Sector:

Our primary products in the Executive Search sector are

 

· FileFinder is an established CRM product with thousands of users Worldwide.

· GatedTalent is a service that helps recruiters source candidates and candidates find jobs and;

· Talentis, our new product launched in January 2021.

 

During 2021 we maintained our commitment to development and product enhancement.

 

· FileFinder: there has been a major project to move FileFinder to a pure Cloud environment which is now live, with the majority of our users serviced from the new platform. User benefits include significant speed gains, while the Group benefits from reduced hosting cost. Costs are inflated in 2021 as the Group operated two platforms, continuing into early 2022 but at a reduced scale with only a small number of clients remaining on the older platform awaiting transfer.

· GatedTalent: extension of our service offering to include additional B2C services including interview coaching. After a slow start, GatedTalent is now cash generative and making a consistent contribution.

· Talentis is a next generation executive search / sourcing and recruiting platform, announced in January 2021, with first revenue in May 2021, and strong momentum going into 2022:

 

o The Talentis TalentGraph now contains information on almost 250 million potential candidates. For certain types of search, Talentis delivers far superior search results through its Augmented Keyword Search technology than current market alternatives.

o Most of Talentis' early adopters were existing group clients paying a nominal fee or, in many cases, receiving the product for free. As a result, while we received our first revenue in May 2021, the product experienced a slow start.

o The slow start means that Talentis annual recurring revenue is currently in the mid five figures. However, realised recurring revenue has doubled every three months since launch, with particular acceleration since late Q4 2021. This acceleration appears on track to continue into Q2 of 2022.

o Talentis became our most popular B2B product in the executive search space in Q4 2021, based on the number of new client wins in the period. In Q1 2022, it became our most popular B2B product across our entire product set based on the same definition.

o Most paying customers are relatively small and are paying a modest subscription fee. However, customer size and subscription value are both expected to grow as the year progresses.

o Talentis has attracted new, paying customers to the Group from 14 countries across 4 continents. The United Kingdom and United States are currently our two largest markets for the product.

o In April 2022, we were pleased to see that the Talentis Chrome Extension was the first executive search focussed product (and one of very few recruitment tools) to receive a "featured" accreditation from Google. "Featured badges" are awarded by Google following a human review to products that "follow Google's technical best practices and meet the company's higher standard for user experience and design".

 

Strategy and Objectives

Our focus during the pandemic revolved around successfully protecting our business while helping our clients and our staff through challenging times. We can now concentrate on our long term strategy which is all about returning to growth. While cost savings were made during the pandemic, we maintained our product development expenditure and targeted it on growth opportunities.

 

This will be achieved by:

 

· Focusing on development expenditures on products serving the executive recruiter sector globally and the contingent recruiting (permanent, temporary and contract) sector.

· Having completed the withdrawal of Evolve from the market in 2019-20, we are in the process of withdrawing a further legacy product from the market, which will complete be in 2022.

· Consistently delivering "best in class" service to our clients, as demonstrated by sector leading Trustpilot scores, despite significant cost savings in recent years.

· Refreshing and reducing the size of the Board.

 

Whilst we have seen growing confidence in the recruitment markets around the world, the global economic challenges that 2022 may bring means that we need to remain focused and responsive to any factors that may hamper the business from returning to growth and profitability.

 

Key Performance Indicators (KPIs)

 

The key KPIs for 2021 were:

KPI

 

2021 outcome

 

Maintain a strong and stable financial position

 

£0.764m cash at year end

 

Protect and prioritise our product and development efforts

 

£0.987m development spend in year

 

Financial Review

 

Total revenues decreased by 12% to £5.599m in 2021 (2020: £6.332m) with recurring revenues decreasing by 13% to £5.009m (2020: £5.745m) and non-recurring revenues by 12% to £0.427m (2020: £0.485m). Third party revenue amounted to £0.163m in the period (2020: £0.102m). 

 

Cost of sales increased to £0.685m (2020: £0.584m). Administrative expenses reduced by 22% to £5.113m (2020: £6.569m), and were covered 127% (2020: 125%) by recurring revenues. This was in part due to the full year impact of the 2020 cost base reductions.

 

Depreciation and amortisation (excluding acquisition related amortisation and one-off write-offs) decreased to £1.122m (2020: £1.334m).

 

Acquisition related and other costs totalled £0.059m (2020: £0.655m) and were in respect of:

· the amortisation of intangibles arising from acquisitions £0.213m (2020: £0.213m).

· grants received from overseas £0.160m (2020: £0.071m)

· other costs of £0.006m (2020: £0.513m)

 

The Group benefitted from an income tax credit in 2021 of £0.302m (2020: credit £0.251m). The 2021 credit reflects the Research and Development (R&D) tax credits available in the UK with the assumption that tax losses will be surrendered for the R&D tax credit payment where possible. It also reflects a prior year adjustment of a credit of £0.181m as the tax computations in respect of prior years were finalised and agreed.

 

Loss for the year before acquisition related and reorganisation and other costs amounted to £0.140m (2020: loss £0.166m). The 2021 adjusted loss benefitted from tax income of £0.287m (2020: tax income of £0.143m). The statutory profit for the year was £0.004m (2020: loss £0.663m). Basic profit/(loss) per share (EPS) was 0.02p (2020: (3.37)p). Fully diluted EPS was to 0.02p (2020: (3.37)p). Adjusted basic EPS increased to 0.24p (2020: (0.59)p).

 

Capital expenditure

 

The Group invested £1.008m in property, plant and equipment and product development in 2021 (2020: £0.971m) of which £0.987m (2020: £0.969m) related to capitalised development costs.

 

Trade and other payables

As with previous years, the trade and other payables includes deferred income of £1.639m (2020: £2.029m), i.e. income which has been billed in advance but is not recognised as income at that time. This principally relates to support, SaaS, cloud hosting renewals and other subscriptions, which are billed in 2021 in respect of services to be delivered in 2022. It also includes licence revenue for which a support contract is required, and which is spread over 5 years under IFRS15. Contractual income is recognised monthly over the period to which it relates. It also includes deposits taken for work which has not yet been completed; as such income is only recognised when the work is substantially complete, or the client software goes "live".

 

Cash and debt

 

The Group finished the year with cash funds of £0.764m (2020: £1.291m). The Group completed repayment of the June 2019 loan in June 2021. The Group obtained a loan of £1.5m in June 2020 under the Government CBIL scheme, which is repayable over 6 years with no repayment in the first year, monthly repayments commenced in July 2021.

 

Bank borrowings at 31 December 2021 were therefore £1.350m (2020: £1.804m). The Group also had a convertible loan of £0.400m (2020: £0.408m) which will not be repaid until the CBIL loan has been repaid.

 

Jason Starr

Chief Executive Officer

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE YEAR ENDED 31 DECEMBER 2021

 

 

 

2021

 

2020

 

Note

 £'000

 

 £'000

 

 

 

 

 

Revenue

5

5,599

 

6,332

 

 

 

 

 

Cost of sales

 

(685)

 

(584)

 

 

 

 

 

Gross profit

 

4,914

 

5,748

 

 

 

 

 

Administrative expenses

 

(5,113)

 

(6,569)

Operating loss

 

(199)

 

(821)

Adjusted operating (loss) before acquisition related, reorganisation and other items

4

(140)

 

(166)

Acquisition related, reorganisation and other items

7

(59)

 

(655)

Operating (loss)

 

(199)

 

(821)

 

 

 

 

 

Financial cost

 

(99)

 

(93)

 

 

 

 

 

(Loss) before tax

 

(298)

 

(914)

 

 

 

 

 

Tax income

8

302

 

251

 

 

 

 

 

Profit/(loss) for the year

 

4

 

(663)

 

 

 

 

 

Other comprehensive income/(loss)

 

 

 

 

Items that will be reclassified subsequently to profit and loss:

 

 

 

 

 

 

 

Currency translation differences

4

12

 

 

 

 

 

Total comprehensive profit/(loss) for the year

 

8

 

(651)

 

Earnings per share

Basic

9

 

0.02p

(3.37)p

Diluted

9

 

0.02p

(3.37)p

 

 

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

FOR THE YEAR ENDED 31 DECEMBER 2021

 

 

 

 Share capital

 Share

premium

Merger

reserve

Convertible

loan reserve

Retained

earnings

 

Share options

 Foreign exchange

 Total

 

 £'000

 £'000

 £'000

£'000

 £'000

 

 £'000

 £'000

£'000

Balance at 1 January 2020

983

1,631

365

14

871

 

94

47

4,005

Comprehensive income

 

 

 

 

 

 

 

 

 

Loss for the year

 -

 -

 -

-

(663)

 

 -

 -

(663)

 

 

 

 

 

 

 

 

 

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

Exchange differences on translation of overseas operations

 -

 -

 -

-

 -

 

 -

12

12

Total comprehensive loss

 

-

-

(663)

 

 -

12

(651)

 

 

 

 

 

 

 

 

 

 

Transactions with owners

 

 

 

 

 

 

 

 

 

Share option charge

 -

 -

 -

-

-

 

16

 -

16

Total transactions with owners

 -

-

-

-

-

 

16

-

16

 

 

 

 

 

 

 

 

 

 

Balance at 31 December 2020

983

1,631

365

14

208

 

110

59

 3,370

 

 

 

 

 

 

 

 

 

 

Comprehensive income

 

 

 

 

 

 

 

 

 

Profit for the year

 -

 -

 -

-

4

 

 -

 -

4

 

 

 

 

 

 

 

 

 

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

Exchange differences on translation of overseas operations

 -

 -

 -

-

 -

 

 -

4

4

 

 

 

 

 

 

 

 

 

 

Total comprehensive loss

-

-

-

-

4

 

 -

4

8

 

 

 

 

 

 

 

 

 

 

Transactions with owners

 

 

 

 

 

 

 

 

 

Share option charge

 -

 -

 -

 

50

 

(46)

 -

4

 

 

 

 

 

 

 

 

 

 

Total transactions with owners

 -

-

-

-

50

 

(46)

-

4

 

 

 

 

 

 

 

 

 

 

Balance at 31 December 2021

983

1,631

365

14

262

 

64

63

3,382

 

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 31 DECEMBER 2021

 

 

 

 

 

 

Group

 

 

 

 

2021

 

2020

 

 

 

 

 £'000

 

 £'000

 

 

ASSETS

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

 

Goodwill

 

3,415

 

3,415

 

 

Other intangible assets

 

3,142

 

3,362

 

 

Property, plant and equipment

 

25

 

24

 

 

Right of use assets

 

592

 

680

 

 

Investments

 

-

 

-

 

 

Total non-current assets

 

7,174

 

7,481

 

 

Current assets

 

 

 

 

 

 

Trade and other receivables

 

615

 

883

 

 

Current tax receivable

 

29

 

186

 

 

Cash and cash equivalents

 

764

 

1,291

 

 

Total current assets

 

1,408

 

2,360

 

 

Total assets

 

8,582

 

9,841

 

 

EQUITY AND LIABILITIES

 

 

 

 

 

 

Equity attributable to owners of the parent

 

 

 

 

 

 

Share capital

 

983

 

983

 

 

Share premium

 

1,631

 

1,631

 

 

Merger reserve

 

365

 

365

 

 

Convertible loan reserve

 

14

 

14

 

 

Retained earnings

 

262

 

208

 

 

Share option reserve

 

64

 

110

 

 

Foreign exchange reserve

 

63

 

59

 

 

Total equity

 

3,382

 

3,370

 

 

Liabilities

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

 

Trade and other payables

 

238

 

271

 

 

Lease liabilities

 

560

 

638

 

 

Borrowings

 

1,450

 

1,749

 

 

Deferred tax liability

 

210

 

296

 

 

Total non-current liabilities

 

2,458

 

2,954

 

 

Current liabilities

 

 

 

 

 

 

Trade and other payables

 

2,347

 

2,953

 

 

Lease liabilities

 

95

 

103

 

 

Borrowings

 

300

 

461

 

 

Total current liabilities

 

2,742

 

3,517

 

 

Total liabilities

 

5,200

 

6,471

 

 

Total liabilities and equity

 

8,582

 

9,841

 

 

         

 

 

CONSOLIDATED CASH FLOW STATEMENT

FOR THE YEAR ENDED 31 DECEMBER 2021

 

 

For the year ended 31 December 2021

 

For the year ended 31 December 2021

 

For the year ended 31 December 2020

 

For the year ended 31 December 2020

Operating activities

£'000

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

 

 

Loss before tax

(298)

 

 

 

(914)

 

 

Adjustment for

 

 

 

 

 

 

 

Financial cost

99

 

 

 

93

 

 

Depreciation and amortisation

1,335

 

 

 

1,984

 

 

Share option expense

3

 

 

 

16

 

 

Foreign exchange adjustments arising from operations

10

 

 

 

(28)

 

 

Operating cash flows before movement in working capital

1,149

 

 

 

1,151

 

 

Decrease in receivables

268

 

 

 

360

 

 

Decrease in payables

(639)

 

 

 

(1,120)

 

 

Taxation refunded

373

 

 

 

314

 

 

Net cash generated from operating activities

 

 

1,151

 

 

 

705

 

 

 

 

 

 

 

 

Investing activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of property, plant and

 

 

 

 

 

 

 

equipment

(21)

 

 

 

(2)

 

 

Investment in development costs

(987)

 

 

 

(969)

 

 

Net cash used in investing activities

 

 

(1,008)

 

 

 

(971)

 

 

 

 

 

 

 

 

Financing activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest paid

(99)

 

 

 

(84)

 

 

Proceeds from bank loan

-

 

 

 

1,500

 

 

Bank loan repayments made

(461)

 

 

 

(166)

 

 

Lease payments made

(104)

 

 

 

(114)

 

 

Repayment of banking facility

-

 

 

 

(288)

 

 

Net cash (used in)/generated from financing activities

 

 

(664)

 

 

 

848

Net (decrease)/increase in cash and cash equivalents

 

(521)

 

 

 

582

Cash and cash equivalents at beginning of the year

 

 

1,291

 

 

 

690

Effect of foreign exchange rate changes

 

 

(6)

 

 

 

19

Cash and cash equivalents at end of year

 

 

764

 

 

 

1,291

 

 

 

 

NOTES TO THE FINANCIAL STATEMENTS

 

FOR THE YEAR ENDED 31 DECEMBER 2021

 

 

1. Publication of non-statutory accounts

 

In accordance with section 435 of the Companies Act 2006, the Directors advise that the financial information set out in this announcement does not constitute the Group's statutory financial statements for the year ended 31 December 2021 or 2020, but is derived from these financial statements. The financial statements for the year ended 31 December 2020 have been audited and filed with the Registrar of Companies. The financial statements for the year ended 31 December 2021 have been prepared in accordance with UK-adopted international accounting standards, IFRIC Interpretations and the Companies Act 2006. The financial statements for the year ended 31 December 2021 have been audited and will be filed with the Registrar of Companies following the Company's Annual General Meeting. The Independent Auditors Report on the Group's statutory financial statements for the years ended 31 December 2021 and 2020 were unqualified and did not draw attention to any matters by way of emphasis and did not contain statements under Section 498(2) or (3) of the Companies Act 2006.

 

2. Basis of preparation

 

The preliminary announcement is extracted from the consolidated financial statements of the Group. The financial statements of the subsidiaries are prepared for the same reporting date as the parent company. Consistent accounting policies are applied for like transactions and events in similar circumstances.

 

All intra-group balances, transactions, income and expenses and profits and losses resulting from intra-group transactions that are recognised in assets or liabilities are eliminated in full.

 

The Group's business activities and financial position, together with the factors likely to affect its future development, performance and position have been taken into account in considering the Group's adoption of the going concern basis. Together with the financial statements, notes, net current liability position and cash flows for the year ended 31 December 2021. The Group prepare 3 year budgets and cash flow forecasts to ensure that the Group can meet its liabilities as they fall due.

 

The Group meets its day to day working capital requirements through its cash balance. It has in place a £1.5m CBIL loan, secured in June 2020, repayable over 6 years with capital repayments commencing from July 2021. The Group did not have an overdraft at the year-end and paid-off a two year bank loan in June 2021. The Group's forecasts, taking into account the Board's future expectations of the Group's performance, indicate that there is sufficient headroom within its CBIL loan facility. Compliance with the CBIL covenant has been considered and based on management expectations and actions, that could practically be taken, the directors do not consider any reasonable risk to arise from this.

 

The cash flow forecasts have been stress tested reviewing assumptions around new and existing business with growth and renewal rates being reduced. A reverse stress test was also prepared to review what reduction in revenue would be necessary to breach overdraft limits in 2022.

 

As at the date of this report, the directors have a reasonable expectation that the Company and the Group have adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.

 

3. Accounting policies

 

This preliminary announcement has been prepared in accordance with the accounting policies adopted in the last annual financial statements for the year to 31 December 2020.

 

4. Reconciliation of adjusted profits to consolidated statement of comprehensive income

 

 

Note

Adjusted profits

Acquisition related, reorganisation and other costs

 

 

Adjusted profits

Acquisition related reorganisation and other costs

 

 

2021

 2021*

2021

 

2020

 2020*

2020

 

 

 

 

 

 

 

 

 

 

£'000

£'000

 £'000

 

£'000

£'000

 £'000

 

 

 

 

 

 

 

 

 

Revenue

 

5,599

 -

5,599

 

6,332

 -

6,332

 

 

 

 

 

 

 

 

 

Cost of sales

 

(685)

 -

(685)

 

(584)

 -

(584)

 

 

 

 

 

 

 

 

 

Gross profit

 

4,914

-

4,914

 

5,748

-

5,748

 

 

 

 

 

 

 

 

 

Administrative expenses

 

(5,054)

(59)

(5,113)

 

(5,914)

(655)

(6,569)

Operating (loss)

 

(140)

(59)

(199)

 

(166)

(655)

(821)

 

 

 

 

 

 

 

 

 

Financial income

 

-

-

-

 

-

-

-

Financial cost

 

(99)

-

(99)

 

(93)

-

(93)

(Loss) before tax

 

(239)

(59)

(298)

 

(259)

(655)

(914)

 

 

 

 

 

 

 

 

 

Tax income

 

 287

15

 302

 

 143

108

 251

Profit/(loss) for the year

 

48

(44)

4

 

(116)

(547)

(663)

Other comprehensive loss net of tax:

 

 

 

 

 

 

 

 

Currency translation differences

 

4

-

4

 

12

-

12

Total comprehensive profit/(loss) for the year net of tax

 

52

(44)

8

 

(104)

(547)

(651)

 

Earnings per share

 

Basic

10

0.24p

-

0.02p

(0.59)p

-

(3.37)p

Diluted

10

0.24p

-

0.02p

(0.59)p

-

(3.37)p

 

* See note 7

 

5. Segment reporting

 

Divisional segments

Ikiru People

Central

Total

 

Ikiru People

Central

Total

 

 

2021

2021

2021

 

2020

2020

2020

 

 

£'000

£'000

£'000

 

£'000

£'000

£'000

 

Segment revenue

5,599

-

5,599

 

6,332

-

6,332

 

Segment EBITDA

953

29

982

 

1,211

(43)

1,168

 

Depreciation and amortisation expense

(1,122)

-

(1,122)

 

(1,334)

-

(1,334)

 

Segment result before reorganisation and other costs

(169)

29

(140)

 

(123)

(43)

(166)

 

Reorganisation and other costs

154

-

154

 

(442)

-

(442)

 

Segment result

(15)

29

14

 

(565)

(43)

(608)

 

Acquisition related amortisation

-

(213)

(213)

 

-

(213)

(213)

 

Operating (loss)

(15)

(184)

(199)

 

(565)

(256)

(821)

 

Loan interest/ lease interest

(35)

(64)

(99)

 

(39)

(54)

(93)

 

Loss before tax

 

 

(298)

 

 

 

(914)

 

Income tax income

 

 

302

 

 

 

251

 

Profit/(loss) for the year

 

 

4

 

 

 

(663)

 

 

 

 

 

 

 

 

 

 

Additions of non-current assets

1,028

 

1,028

 

1,006

 

1,006

 

 

 

Products and services

The following table provides an analysis of the Group's revenue by products and services:

 

Revenue

 

 

 

 

2021

 

2020

 

 

 

 

 £'000

 

 £'000

Recurring income

 

 

5,009

 

5,745

Non-recurring income

 

 

427

 

485

Third party revenues

 

 

163

 

102

 

 

 

 

5,599

 

6,332

        

 

In the table above 'Recurring income' represents all income recognised over time, whereas 'Non-recurring income' and 'Third party revenues' represent all income recognised at a point in time. 

 

Recurring income includes all support services, SaaS and hosting income and revenue on perpetual licenses with mandatory support contracts deferred under IFRS 15. Non-recurring income includes sales of new licenses which do not require a support contract, and income derived from installing licences including training, installation and data translation. Third party revenues arise from the sale of third party software.

 

It is not possible to allocate assets and additions between recurring, non-recurring income and third party revenue. No customer represented more than 10% of revenue of the Group in 2021 or 2020.

 

6. Geographical analysis

 

The following table provides an estimated of the Group's revenue by geographic market based on the Customers' country. This is provided for information only as the Board does not review the performance of the business from a geographical viewpoint. 

 

Revenue

 

 

 

 

2021

 

2020

 

 

 

 

 £'000

 

 £'000

UK

 

 

3,933

 

3,717

 

Europe

 

 

762

 

877

 

Americas

 

 

526

 

1,074

 

Australia

 

 

140

 

295

 

ROW

 

 

238

 

369

 

 

 

 

5,599

 

6,332

 

         

 

Non-current assets by geographical location

 

 

 

 

2021

 

2020

 

 

 

 

 £'000

 

 £'000

UK

 

 

7,169

 

7,460

US

 

 

1

 

1

Australia

 

 

4

 

20

 

 

 

 

7,174

 

7,481

         

 

7. Acquisition related, reorganisation and other costs

 

 

 

2021

 

2020

 

 

 

 £'000

 

 £'000

Included within administrative expenses:

 

 

 

 

 

Reorganisation and other costs

 

 

6

 

78

US government loan (Payment Protection Program)

 

 

(154)

 

-

Australian government grant

 

 

(6)

 

(71)

Amortisation of acquisition intangibles

 

 

213

 

213

Write-off of capitalised development

 

 

-

 

435

 

 

 

59

 

655

 

Reorganisation and other costs include severance payments and loss of office payments. The write-off of capitalised development relates to a product that is no longer actively sold.

 

8. Tax income

 

 

 

 

 

 

 

 

 

2021

 

2020

 

 

 

 £'000

 

 £'000

 

 

 

 

 

 

Current tax

 

 

(96)

 

(99)

Prior year adjustment - current tax

 

 

(121)

 

(108)

Total current tax

 

 

(217)

 

(207)

 

 

 

 

 

 

Deferred tax

 

 

(35)

 

(123)

Prior year adjustment - deferred tax

 

 

(60)

 

80

Deferred tax rate change to 25% (2020: 19.0%)

 

 

50

 

40

Deferred tax re acquisition intangibles

 

 

(40)

 

(41)

Total deferred tax

 

(85)

 

(44)

Tax (income) for the year

 

(302)

 

(251)

 

 

 

 

 

 

 

 

Factors affecting the tax credit for the year

 

 

 

Loss before tax

 

 

(298)

 

(914)

UK rate of taxation

 

 

19.0%

 

19.0%

Loss before tax multiplied by the UK rate of taxation

(57)

 

(174)

 

 

 

 

 

 

Effects of:

 

 

 

 

 

Overseas tax rates

 

 

(6)

 

1

Impact of deferred tax not provided

 

 

(1)

 

8

Enhanced R&D relief

 

 

(146)

 

(143)

Disallowed expenses

18

 

14

Deferred tax rate change to 25% (2020: 19.0%)

 

 

41

 

40

Rate difference between CT rate and rate of R&D repayment

 

 

30

 

31

Prior year adjustments

 

 

(181)

 

(28)

Tax (income)

 

 

(302)

 

(251)

        

 

9. Earnings per share

 

 

2021

 

2020

 

 

Using adjusted profit

2021

Using adjusted profit

2020

 

 

 

 

 

Profit/(loss) attributable to ordinary shareholders (note 2)

£48,000

£4,000

£(116,000)

£(663,000)

Weighted average number of shares

19,668,021

19,668,021

19,668,021

19,668,021

Basic profit/(loss) per share

0.24 p

0.02 p

(0.59) p

(3.37) p

Weighted average number of shares after dilution

19,668,021

19,668,021

19,670,013

19,670,013

Fully diluted profit/(loss) per share

0.24 p

0.02 p

(0.59) p

(3.37) p

 

 

Reconciliation of basic to diluted average number of shares:

 

 

 

 

2021

 

2020

 

 

 

 

 

 

 

Weighted average number of shares (basic)

 

 

19,668,021

 

19,668,021

Effect of dilutive potential ordinary shares - employee share plans

 

 

-

 

1,992

Weighted average number of shares after dilution

 

19,668,021

 

19,670,013

        

 

There are 493,337 (2020: 953,337) share options not included in the above calculations, as they are underwater or have been forfeited.

 

The impact of the convertible loan notes in the period is not dilutive and therefore does not impact the calculation of the fully diluted earnings per share.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR FZGZDNKLGZZM
Date   Source Headline
25th Apr 20247:00 amRNSFinal Results & Investor Presentation
22nd Apr 20247:00 amRNSNotice of Results & Investor Presentation
9th Apr 20247:00 amRNSBlock listing Interim Review
30th Jan 20247:00 amRNSTrading Update & Notice of Results
9th Oct 20237:00 amRNSBlock listing Interim Review
26th Sep 20237:00 amRNSInterim Results & Investor Presentations
18th Sep 20237:00 amRNSNotice of Results & Investor Presentations
13th Jun 20231:18 pmRNSResult of AGM
13th Jun 20237:00 amRNSAGM Statement
25th Apr 20237:00 amRNSFinal Results & Investor Presentation
11th Apr 20237:00 amRNSBlock listing Interim Review
30th Mar 20237:00 amRNSContract & Notice of Results
2nd Feb 20237:00 amRNSTrading Update & Notice of Results
7th Nov 20227:00 amRNSDirector Dealings
10th Oct 20227:00 amRNSBlock listing Interim Review
26th Sep 20227:01 amRNSDirectorate Changes
26th Sep 20227:00 amRNSInterim Results & Investor Presentation
20th Sep 20227:00 amRNSNotice of Results & Investor Presentation
16th Jun 20228:00 amRNSIssue of Options
15th Jun 202212:15 pmRNSResult of AGM
15th Jun 20227:00 amRNSAGM Statement
23rd May 20227:00 amRNSDSG presenting at Mello2022 Investor Conference
26th Apr 20227:01 amRNSDirectorate Change
26th Apr 20227:00 amRNSFinal Results & Investor Presentation
11th Apr 20227:00 amRNSBlock listing Interim Review
3rd Feb 20227:00 amRNSTrading Update & Notice of Final Results
19th Jan 20227:00 amRNSMajor Contract Extension
7th Dec 20217:00 amRNSLarge UK Client Contract Award
11th Oct 20217:00 amRNSBlock listing Interim Review
4th Oct 20217:00 amRNSIssue of Options
23rd Sep 20217:00 amRNSInterim Results
20th Aug 20217:00 amRNSBoard Changes
16th Jun 202111:40 amRNSResult of AGM
16th Jun 20217:00 amRNSAGM Statement & Board Changes
29th Apr 20217:00 amRNSFinal Results
9th Apr 20217:00 amRNSBlock listing Interim Review
29th Mar 20217:00 amRNSDirector/PDMR Shareholding
11th Feb 202110:51 amRNSHolding(s) in Company
11th Feb 20217:00 amRNSIssue of Options
28th Jan 20217:02 amRNSLaunch of Talentis & The TalentGraph - Webinar
28th Jan 20217:01 amRNSDirector Appointment
28th Jan 20217:00 amRNSTrading Update
27th Nov 20201:15 pmRNSIssue of Options
13th Oct 20204:51 pmRNSBlock listing Interim Review
25th Sep 202010:46 amRNSResult of AGM
23rd Sep 20201:06 pmRNSResult of AGM
23rd Sep 20207:00 amRNSInterim Results
30th Jul 20207:00 amRNSFinal Results
29th Jun 20207:00 amRNSNotice of Results
4th Jun 20207:00 amRNSBank Loan, Trading Update & Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.